Literature DB >> 29241774

Trends in Medicare spending on topical immunomodulators and chemotherapies.

Hannah Song1, Adewole S Adamson2, Arash Mostaghimi3.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 29241774     DOI: 10.1016/j.jaad.2017.07.056

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  2 in total

1.  Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.

Authors:  David G Li; Cara Joyce; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2018-12-01       Impact factor: 10.282

2.  Use and Cost of Actinic Keratosis Destruction in the Medicare Part B Fee-for-Service Population, 2007 to 2015.

Authors:  Howa Yeung; Marissa L Baranowski; Robert A Swerlick; Suephy C Chen; Jennifer Hemingway; Danny R Hughes; Richard Duszak
Journal:  JAMA Dermatol       Date:  2018-11-01       Impact factor: 10.282

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.